WASHINGTON, D.C., June 17, 2026―Duane Morris LLP advised Veraxa Biotech AG, an emerging leader in designing novel cancer therapies, in completing its go-public transaction with special purpose acquisition company Voyager Acquisition Corp. Veraxa commenced trading its shares under the symbol “VRXA” and its warrants under the symbol “VRXAW” on the Nasdaq Capital Market.
Veraxa is developing a new generation of bispecific T-cell engaging (TCE) molecules and antibody drug conjugates (ADC) aimed at increasing patient benefit through enlarging the therapeutic window and maximizing safety and efficacy. Central to Veraxa’s strategy is the use of its proprietary technology platform BiTAC (bi-targeted tumor-associated cytotoxicity), which enables the creation of conditionally activated, AND-gated therapeutic strategies that precisely target cancer cells while leaving healthy cells intact. Proceeds from the financings will provide Veraxa with the ability to advance its pipeline of BiTAC-TCE and BiTAC-ADC programs toward clinical development and through initial value inflection points. The financings are comprised of a senior secured note in the principal amount of $27.5 million and a securities purchase agreement of up to $50 million.
A team of lawyers led by Washington, D.C., partner Andy Tucker and Atlanta partner Rebekah D. McCorvey along with associates Alisha Peters in Austin, Leticia Pavlak in Atlanta, Hallie Baggaley in Philadelphia and Luis Ferro in Miami were counsel to Veraxa in the transaction. The transaction was also supported by benefits partner John A. Reade and tax partner Stephen DiBonaventura.
About Duane Morris
Duane Morris LLP provides innovative solutions to today’s multifaceted legal and business challenges through the collegial and collaborative culture of its more than 900 attorneys in offices across the United States and internationally. The firm represents a broad array of clients, spanning all major practices and industries. Duane Morris has been recognized by BTI Consulting as both a client service leader and a highly recommended law firm.
